Assessing short‐term and long‐term security and efficacy of anterior nucleus of the thalamus deep brain stimulation for treating drug‐resistant epilepsy: A systematic review and single‐arm meta‐analysis

脑深部刺激 癫痫 医学 荟萃分析 抗药性癫痫 置信区间 系统回顾 内科学 癫痫外科 麻醉 梅德林 精神科 生物 生物化学 疾病 帕金森病
作者
Gabriel Verly,Leonardo de Barros Oliveira,Thiffany Delfino,Sávio Batista,Thiago Castro Lopes,Vitória Rodrigues Reis Carvalho,Billy McBenedict,Matheus Fernandes de Oliveira,Raphael Bertani,Pedro Henrique Martins da Cunha,Wellingson Silva Paiva,Bruno Lima Pessôa
出处
期刊:Epilepsia [Wiley]
卷期号:65 (6): 1531-1547 被引量:1
标识
DOI:10.1111/epi.17955
摘要

Abstract Deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) is a widespread invasive procedure for treating drug‐resistant epilepsy. Nonetheless, there is a persistent debate regarding the short‐term and long‐term efficacy and safety of ANT‐DBS. Thus we conducted a systematic review and meta‐analysis. Following Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA), we searched PubMed, Cochrane, Embase, and Web of Science for studies treating refractory epilepsy with ANT‐DBS. Short‐term analysis was considered for studies with a mean follow‐up of 3 years or less. The following outcomes were assessed for data extraction: procedure responders and nonresponders, increased seizure frequency, complications, and procedure‐related mortality. Of 650 studies, 25 fit our inclusion criteria, involving 427 patients. Previous surgical treatments have been reported in 214 patients (50.1%) and a median average baseline seizure frequency of 64.9 monthly seizures. In the short‐term analysis, we observed a proportion of 67% (95% confidence interval [CI] 54%–79%) of responders and 33% (95% CI 21%–46%) of nonresponders. In addition, 4% (95% CI 0%–9%) of the patients presented increased seizure frequency. In the long‐term analysis, we observed 72% (95% CI 66%–78%) responders and 27% (95% CI 21%–34%) nonresponders. Moreover, there was a 2% (95% CI 0%–5%) increase in seizure frequency. No procedure‐related mortality was reported at any follow‐up. ANT‐DBS effectively treats refractory epilepsy, with lasting short‐term and long‐term benefits. It remains safe and efficient despite complications, showing no procedure‐linked fatalities, high patient responsiveness, and minimal increased seizures. Consistent results over time and low morbidity/mortality rates emphasize its worth. Further research is necessary to diminish the discrepancy among results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
嘻哈学习发布了新的文献求助10
刚刚
czc发布了新的文献求助10
1秒前
无人深空发布了新的文献求助10
1秒前
zzulyy发布了新的文献求助10
1秒前
2秒前
琪小7完成签到,获得积分10
2秒前
3秒前
NICOHUK完成签到,获得积分10
4秒前
4秒前
认真科研关注了科研通微信公众号
7秒前
深海的孤独哀完成签到,获得积分10
7秒前
8秒前
鑫儿宝完成签到,获得积分20
8秒前
9秒前
NikiJu完成签到,获得积分10
9秒前
Shai发布了新的文献求助10
10秒前
10秒前
11秒前
钙钛矿科研狗完成签到,获得积分20
11秒前
11秒前
无人深空完成签到,获得积分10
12秒前
12秒前
12秒前
赘婿应助寒素采纳,获得10
12秒前
caicai完成签到,获得积分20
13秒前
帅气的马里奥完成签到 ,获得积分10
13秒前
我是老大应助马尔沙采纳,获得10
13秒前
14秒前
14秒前
zhangwei应助123采纳,获得10
14秒前
爱科研爱生活完成签到,获得积分20
15秒前
caicai发布了新的文献求助10
16秒前
liuyu发布了新的文献求助10
16秒前
16秒前
Simin完成签到 ,获得积分10
16秒前
16秒前
16秒前
xtutang发布了新的文献求助10
17秒前
热心烙发布了新的文献求助10
17秒前
叮咚发布了新的文献求助10
17秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
An Introduction to Geographical and Urban Economics: A Spiky World Book by Charles van Marrewijk, Harry Garretsen, and Steven Brakman 600
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 400
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3152854
求助须知:如何正确求助?哪些是违规求助? 2804064
关于积分的说明 7856939
捐赠科研通 2461847
什么是DOI,文献DOI怎么找? 1310502
科研通“疑难数据库(出版商)”最低求助积分说明 629279
版权声明 601788